CNOT2_HUMAN - dbPTM
CNOT2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CNOT2_HUMAN
UniProt AC Q9NZN8
Protein Name CCR4-NOT transcription complex subunit 2
Gene Name CNOT2
Organism Homo sapiens (Human).
Sequence Length 540
Subcellular Localization Cytoplasm . Nucleus .
Protein Description Component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation. Additional complex functions may be a consequence of its influence on mRNA expression. Required for the CCR4-NOT complex structural integrity. Can repress transcription and may link the CCR4-NOT complex to transcriptional regulation; the repressive function may specifically involve the N-Cor repressor complex containing HDAC3, NCOR1 and NCOR2. Involved in the maintenance of emryonic stem (ES) cell identity..
Protein Sequence MVRTDGHTLSEKRNYQVTNSMFGASRKKFVEGVDSDYHDENMYYSQSSMFPHRSEKDMLASPSTSGQLSQFGASLYGQQSALGLPMRGMSNNTPQLNRSLSQGTQLPSHVTPTTGVPTMSLHTPPSPSRGILPMNPRNMMNHSQVGQGIGIPSRTNSMSSSGLGSPNRSSPSIICMPKQQPSRQPFTVNSMSGFGMNRNQAFGMNNSLSSNIFNGTDGSENVTGLDLSDFPALADRNRREGSGNPTPLINPLAGRAPYVGMVTKPANEQSQDFSIHNEDFPALPGSSYKDPTSSNDDSKSNLNTSGKTTSSTDGPKFPGDKSSTTQNNNQQKKGIQVLPDGRVTNIPQGMVTDQFGMIGLLTFIRAAETDPGMVHLALGSDLTTLGLNLNSPENLYPKFASPWASSPCRPQDIDFHVPSEYLTNIHIRDKLAAIKLGRYGEDLLFYLYYMNGGDVLQLLAAVELFNRDWRYHKEERVWITRAPGMEPTMKTNTYERGTYYFFDCLNWRKVAKEFHLEYDKLEERPHLPSTFNYNPAQQAF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
12UbiquitinationDGHTLSEKRNYQVTN
CCCCCCCCCCHHHHH
42.44-
15PhosphorylationTLSEKRNYQVTNSMF
CCCCCCCHHHHHHCC
14.3727642862
20PhosphorylationRNYQVTNSMFGASRK
CCHHHHHHCCCCCHH
13.2128555341
35PhosphorylationKFVEGVDSDYHDENM
HHHHCCCCCCCCCCC
37.3528796482
37PhosphorylationVEGVDSDYHDENMYY
HHCCCCCCCCCCCCC
18.3428796482
43PhosphorylationDYHDENMYYSQSSMF
CCCCCCCCCCCCCCC
16.1428796482
44PhosphorylationYHDENMYYSQSSMFP
CCCCCCCCCCCCCCC
6.8928796482
45PhosphorylationHDENMYYSQSSMFPH
CCCCCCCCCCCCCCC
13.1928796482
47PhosphorylationENMYYSQSSMFPHRS
CCCCCCCCCCCCCCC
20.1728796482
48PhosphorylationNMYYSQSSMFPHRSE
CCCCCCCCCCCCCCH
19.4628796482
54PhosphorylationSSMFPHRSEKDMLAS
CCCCCCCCHHHCCCC
46.0627251275
56AcetylationMFPHRSEKDMLASPS
CCCCCCHHHCCCCCC
50.087467815
61PhosphorylationSEKDMLASPSTSGQL
CHHHCCCCCCCCHHH
18.5428450419
63PhosphorylationKDMLASPSTSGQLSQ
HHCCCCCCCCHHHHH
32.4828450419
64PhosphorylationDMLASPSTSGQLSQF
HCCCCCCCCHHHHHH
40.0228450419
65PhosphorylationMLASPSTSGQLSQFG
CCCCCCCCHHHHHHC
28.9528450419
69PhosphorylationPSTSGQLSQFGASLY
CCCCHHHHHHCHHHH
18.6428450419
74PhosphorylationQLSQFGASLYGQQSA
HHHHHCHHHHHHHHC
23.6227080861
76PhosphorylationSQFGASLYGQQSALG
HHHCHHHHHHHHCCC
15.4727080861
80PhosphorylationASLYGQQSALGLPMR
HHHHHHHHCCCCCCC
19.9927080861
87MethylationSALGLPMRGMSNNTP
HCCCCCCCCCCCCCH
35.40115389015
89SulfoxidationLGLPMRGMSNNTPQL
CCCCCCCCCCCCHHH
2.4621406390
90PhosphorylationGLPMRGMSNNTPQLN
CCCCCCCCCCCHHHH
29.7430243723
93PhosphorylationMRGMSNNTPQLNRSL
CCCCCCCCHHHHHHH
19.3629255136
99PhosphorylationNTPQLNRSLSQGTQL
CCHHHHHHHHCCCCC
31.1626055452
101PhosphorylationPQLNRSLSQGTQLPS
HHHHHHHHCCCCCCC
28.0117525332
104PhosphorylationNRSLSQGTQLPSHVT
HHHHHCCCCCCCCCC
21.2128450419
108PhosphorylationSQGTQLPSHVTPTTG
HCCCCCCCCCCCCCC
38.9028450419
111PhosphorylationTQLPSHVTPTTGVPT
CCCCCCCCCCCCCCC
14.9721712546
113O-linked_GlycosylationLPSHVTPTTGVPTMS
CCCCCCCCCCCCCEE
27.1530059200
113PhosphorylationLPSHVTPTTGVPTMS
CCCCCCCCCCCCCEE
27.1525394399
114PhosphorylationPSHVTPTTGVPTMSL
CCCCCCCCCCCCEEC
37.0728450419
118PhosphorylationTPTTGVPTMSLHTPP
CCCCCCCCEECCCCC
19.5821082442
120PhosphorylationTTGVPTMSLHTPPSP
CCCCCCEECCCCCCC
21.3421712546
123PhosphorylationVPTMSLHTPPSPSRG
CCCEECCCCCCCCCC
42.0326055452
126PhosphorylationMSLHTPPSPSRGILP
EECCCCCCCCCCCCC
36.3926055452
128PhosphorylationLHTPPSPSRGILPMN
CCCCCCCCCCCCCCC
47.6930177828
137MethylationGILPMNPRNMMNHSQ
CCCCCCHHHCCCHHH
38.38115485459
141 (in isoform 3)Ubiquitination-22.3821906983
143PhosphorylationPRNMMNHSQVGQGIG
HHHCCCHHHCCCCCC
22.8928857561
155PhosphorylationGIGIPSRTNSMSSSG
CCCCCCCCCCCCCCC
35.6623927012
157PhosphorylationGIPSRTNSMSSSGLG
CCCCCCCCCCCCCCC
21.3023401153
159PhosphorylationPSRTNSMSSSGLGSP
CCCCCCCCCCCCCCC
22.6023927012
160PhosphorylationSRTNSMSSSGLGSPN
CCCCCCCCCCCCCCC
21.5623401153
161PhosphorylationRTNSMSSSGLGSPNR
CCCCCCCCCCCCCCC
30.6323401153
165PhosphorylationMSSSGLGSPNRSSPS
CCCCCCCCCCCCCCC
24.8419664994
169O-linked_GlycosylationGLGSPNRSSPSIICM
CCCCCCCCCCCEEEE
53.9230059200
169PhosphorylationGLGSPNRSSPSIICM
CCCCCCCCCCCEEEE
53.9223401153
170PhosphorylationLGSPNRSSPSIICMP
CCCCCCCCCCEEEEC
21.3022167270
172PhosphorylationSPNRSSPSIICMPKQ
CCCCCCCCEEEECCC
26.9122167270
190PhosphorylationRQPFTVNSMSGFGMN
CCCCEEECCCCCCCC
15.2528555341
242PhosphorylationDRNRREGSGNPTPLI
HCCCCCCCCCCCCCC
30.5529255136
246PhosphorylationREGSGNPTPLINPLA
CCCCCCCCCCCCCCC
34.4225159151
258PhosphorylationPLAGRAPYVGMVTKP
CCCCCCCEEEEEECC
14.5124275569
270PhosphorylationTKPANEQSQDFSIHN
ECCCCCCCCCCCCCC
26.0723312004
274PhosphorylationNEQSQDFSIHNEDFP
CCCCCCCCCCCCCCC
31.0928555341
286PhosphorylationDFPALPGSSYKDPTS
CCCCCCCCCCCCCCC
28.6725627689
293PhosphorylationSSYKDPTSSNDDSKS
CCCCCCCCCCCCCCC
32.31-
294PhosphorylationSYKDPTSSNDDSKSN
CCCCCCCCCCCCCCC
46.91-
299AcetylationTSSNDDSKSNLNTSG
CCCCCCCCCCCCCCC
50.817960613
304PhosphorylationDSKSNLNTSGKTTSS
CCCCCCCCCCCCCCC
41.8629214152
305PhosphorylationSKSNLNTSGKTTSST
CCCCCCCCCCCCCCC
36.9028985074
307UbiquitinationSNLNTSGKTTSSTDG
CCCCCCCCCCCCCCC
48.69-
308PhosphorylationNLNTSGKTTSSTDGP
CCCCCCCCCCCCCCC
35.1221712546
309PhosphorylationLNTSGKTTSSTDGPK
CCCCCCCCCCCCCCC
24.9428348404
310PhosphorylationNTSGKTTSSTDGPKF
CCCCCCCCCCCCCCC
36.1528348404
311PhosphorylationTSGKTTSSTDGPKFP
CCCCCCCCCCCCCCC
28.5528348404
312PhosphorylationSGKTTSSTDGPKFPG
CCCCCCCCCCCCCCC
44.7528348404
315 (in isoform 2)Ubiquitination-37.6121906983
321UbiquitinationGPKFPGDKSSTTQNN
CCCCCCCCCCCCCCC
52.82-
380PhosphorylationMVHLALGSDLTTLGL
CEEEECCCCCEEECC
30.2320068231
383PhosphorylationLALGSDLTTLGLNLN
EECCCCCEEECCCCC
25.6020068231
384PhosphorylationALGSDLTTLGLNLNS
ECCCCCEEECCCCCC
26.5620068231
391PhosphorylationTLGLNLNSPENLYPK
EECCCCCCHHHCCCC
36.4429523821
396PhosphorylationLNSPENLYPKFASPW
CCCHHHCCCCCCCCC
18.8920090780
401PhosphorylationNLYPKFASPWASSPC
HCCCCCCCCCCCCCC
24.9028348404
405PhosphorylationKFASPWASSPCRPQD
CCCCCCCCCCCCCCC
30.8325159151
406PhosphorylationFASPWASSPCRPQDI
CCCCCCCCCCCCCCC
21.9225159151
440 (in isoform 5)Ubiquitination-22.1521906983
471PhosphorylationLFNRDWRYHKEERVW
HHCCCCCCCCCCCEE
17.0024719451
480PhosphorylationKEERVWITRAPGMEP
CCCCEEEEECCCCCC
12.6924719451
490UbiquitinationPGMEPTMKTNTYERG
CCCCCCCCCCCEECC
40.892190698
490 (in isoform 1)Ubiquitination-40.8921906983
494PhosphorylationPTMKTNTYERGTYYF
CCCCCCCEECCEEEE
13.0030576142
499PhosphorylationNTYERGTYYFFDCLN
CCEECCEEEEEEECC
10.9130576142
500PhosphorylationTYERGTYYFFDCLNW
CEECCEEEEEEECCH
9.52-
512UbiquitinationLNWRKVAKEFHLEYD
CCHHHHHHHHCCCHH
64.99-
520UbiquitinationEFHLEYDKLEERPHL
HHCCCHHHHHCCCCC
57.82-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
101SPhosphorylationKinaseATRQ13535
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CNOT2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CNOT2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CNOT3_HUMANCNOT3physical
16189514
NCOR2_HUMANNCOR2physical
16712523
NCOR1_HUMANNCOR1physical
16712523
GPS2_HUMANGPS2physical
16712523
CNOT1_HUMANCNOT1physical
16778766
CNOT3_HUMANCNOT3physical
16778766
CNOT8_HUMANCNOT8physical
16778766
CA2D1_HUMANCACNA2D1physical
26496610
DDX11_HUMANDDX11physical
26496610
FHL2_HUMANFHL2physical
26496610
IF6_HUMANEIF6physical
26496610
CNOT3_HUMANCNOT3physical
26496610
DPOD1_HUMANPOLD1physical
26496610
RENT1_HUMANUPF1physical
26496610
RL12_HUMANRPL12physical
26496610
RT12_HUMANMRPS12physical
26496610
XPO1_HUMANXPO1physical
26496610
CNOT9_HUMANRQCD1physical
26496610
CNOT8_HUMANCNOT8physical
26496610
CNOT1_HUMANCNOT1physical
26496610
UBP24_HUMANUSP24physical
26496610
LARP1_HUMANLARP1physical
26496610
CNO10_HUMANCNOT10physical
26496610
S18L2_HUMANSS18L2physical
26496610
CNO11_HUMANCNOT11physical
26496610
KANL3_HUMANKANSL3physical
26496610
TM165_HUMANTMEM165physical
26496610
AKIP1_HUMANAKIP1physical
26496610
DDX24_HUMANDDX24physical
26496610
WDR26_HUMANWDR26physical
26496610
TB182_HUMANTNKS1BP1physical
26496610
CNKR3_HUMANCNKSR3physical
26496610
CNO6L_HUMANCNOT6Lphysical
26496610
CNO11_HUMANCNOT11physical
27173435
CNOT6_HUMANCNOT6physical
27173435
CNOT7_HUMANCNOT7physical
27173435
CNO10_HUMANCNOT10physical
27173435
CNOT9_HUMANRQCD1physical
27173435
CNOT1_HUMANCNOT1physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CNOT2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-126 AND SER-165, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-93 AND SER-165, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-101, AND MASSSPECTROMETRY.

TOP